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Dexamethasone bovine pharmacokinetics
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SUMMARY
Dexamethasone phosphate (DXM-PHO) is an ester which is quickly hydrolysed by the bovine and the dexamethasone (DXM) plasma
half-life was 5.16 h. It has been demonstrated that 54 h after DXM-PHO injection, DXM concentrations were lower than 0.1 mglml.
Tritiated dexamethasone was also administered twice to an another young bull for metabolite investigation. The elapsed time
required to recover, in plasma, half of the radioactivity injected was 8.8 h. Radioactivity recovery in the urine reached 36.4% and
22.6% for the first and the second injections respectively.
INTRODUCTION
Dexamethasone (DXM) and dexamethasone esters
(phenylpropionate, sodium-phosphate, isonicotinate)
are among the most potent fluorinated synthetic
glucocoritcoids widely used in human and veterinary
practice for their anti-inflammatory, anti-allergic and
anti-rheumatic properties. For several years, it has
been known that these compounds have also been
illicitly administered as 'hormones' to improve the
phenotype of beef cattle at the end of the fattening
period (1, 2).
The accumulation of such molecules and their
metabolites in organs and meat could represent a
potential hazard for the consumer's health which is
still difficult to evaluate. Investigations of residues (in
plasma and urine) are not easy due to the many
interfering compounds resulting from general
metabolism of the animal. Moreover, other factors
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such as the misreading of the drug, the low quantities
injected, the number of treatments, the delay between
the injection and slaughtering and the nature of the
treatment (intramuscular, intravenous, or others) can
considerably affect the possibilities of detecting traces
of these molecules.
This paper describes the study, by radioimmuno-
assay (RIA), of the DXM sodium-phosphate (DXM-
PHO) phannacoldnetics in young cattle. Plasma
half-life of the DXM, liberated from the ester, and the
period in which DXM is still detectable have been
determined, In further investigations on DXM
metabolism, tritiated DXM was administered to
another bull. Pharmacokinetics of the total radio-
activity (tritiated DXM + related tritiated compounds)
have also been studied and recovery of radioactive
compounds from the urine was assessed.
MATERIALS AND METHODS
Plasma DXM concentrations were determined by RIA
following the method described by Lejeune-Lenain et










































Fig. 1 : Semi-logarithmic plots of the disposition curve of dexamethasone phosphate in bovine plasma
Open squares - first injection, filled diamonds - second injection
al. (3). Cross-reactivities with the main endogenous
steroids (including cortisol) were lower than 0.1%.
scintillation liquid (Lumagel), vials were counted for
10 min in a Beckman (No. LS 7500) ~-scintillator.
Blanks were collected from the same animal before
treatment.
Chemicals
Dexamethasone (DXM) was purchased from
Steralotds, the monoclonal antiserum against DXM,
from IgG Corporation (Nashville, USA) and dexa-
methasone-21-Na-phosphate (DXM-PHO), (Decadron)
from Merck. Sharp and Dohme (Germany), Labelled
1,2,4-eH]-DXM was purchased from Amersham (UK:
code number = TRK 417).
Animals
Two young Pie-Noir bulls weighing 280 kg (animal 1,
experiment I) and 235 kg (animal 4, experiment m
and identical Pie-Noir cattle twins weighing 124 kg
(animal 2, experiment I) and 132 kg (animal 3,
experiment I) were placed in metabolism boxes and
allowed hay, granules and water ad libitum.
Treatments and sampling
Decadron (0.1 mglkg body weight) was injected in the
left jugular vein and the animals were catheterized in
the right jugular vein to minimize disturbances during
blood sampling. Blood samples (10 ml) were
collected at frequent intervals on the first day, put into
ice-cold heparinized tubes and inunediately
centrifuged.
Animal 4 was injected first with 400 J.l.Ci of
tritiated DXM and 9 days later with 483 J.l.Ci. Radio-
active plasma and urine samples were directly trans-
ferred to scintillation vials. After addition of 10 ml of
RESULTS AND DISCUSSION
Experiment 1: DXM·PHO in plasma
DXM plasma concentrations are shown in semi-
logarithmic plots (Fig. 1). Maximum levels (> 700 ng
DXM/ml plasma) occurred during the first 15 min
following the administration. After 30 min, and for
five consecutive experiments, DXM concentrations
decreased very sharply and showed values ranging
from 72-20 ng/ml plasma.
Semi-logarithmic regression analyses gave 5.46 h
as the mean plasma half-life (SD = 0.26, n = 5).
In each experiment, DXM concentrations were
below 0.1 ng/ml, 54 h post-injection. Pharmaco-
kinetics were established on the basis of 8 DXM RIA
values and each measurement was repeated 3 times.
In dairy cows, Fairclough et al, (4) demonstrated
that a 20 mg DXM-PHO intramuscular injection led to
70-24 ng/ml plasma maximum levels within 2-20 min
and DXM concentrations were lower than 0.15 ng/rnl
after 72 h.
The results of our study agree very well with those
of Tainturier et al. (5), who calculated a 4.5 h plasma
half-life after a 0.1 mglk.g DXM isonicotinate
intravenous injection to dairy cows. In cattle, Toutain
et al. (6) observed 5.58 and 4:5 h plasma half-life after
DXM and DXM isonicotinate intravenous injection,
respectively.
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Fig. 3 : Radioactivity recovery in bovine urine following two
intravenous injections of tritiated dexamethasone
Solid area = first injection





















Fig. 2 : Semi-logarithmic plots of the elimination of
radioactivity (DXM + related compounds) in bovine
plasma
Open squares = first injection































Experiment II: Tritiated DXM in plasma
and urine
Pharmacokinetics I and IT (on total radioactivity) were
determined with 27 and 25 values respectively
(Fig. 2).
Maximum radioactivity levels in plasma occurred
during the first 15 min following the two injections
and the residual radioactivity was estimated at 0.09
IlCi (0.02% of 400 IlCi administered) just before the
second injection.
For both pharmacokinetics, the radioactivity levels
declined very slowly to become insignificant « 0.05
IlCi), 11 days after the second treatment
During the first 24 h, the elapsed time to recover
half of the radioactivity was 8.8 h for both injections.
This value, higher than that obtained for DXM, is a
global measurement involving tritiated DXM and
other related tritiated compounds produced,
particularly DXM metabolites. In addition to the two
blood sampling periods (9 and 12 days), urine samples
were also collected in order to estimate the
radioactivity excreted daily (Fig. 3).
The total cumulative radioactivity recovered in
urine 216 h after the administration, was 36.4% (first
injection) and 22.6% (second injection). The number
and the identification of DXM metabolites will be
reported later.
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